Open position for a Research Assistant / Postdoctoral Fellow

The Prostate Cancer Biology group directed by Dr. Giuseppina Carbone at the Institute of Oncology Research in Bellinzona, Switzerland, is seeking a Research Assistant / Postdoctoral Fellow. The Institute of Oncology Research (IOR) in Bellinzona, Switzerland, is a rapidly evolving, leading center for basic and translational research in oncology in Europe. The aim of our research is to decode the mechanisms of cancer pathogenesis and develop innovative and rational-based avenues to fight cancer...
More

A molecular switch turns on the unfavorable evolution of prostate tumors

Background Prostate cancer is one of the most common malignancies and causes of mortality in men worldwide. About 50% of prostate tumors (ERG fusion-positive prostate cancers) harbor a fusion between the ERG gene and the promoter region of TMPRSS2 gene. This chromosomal rearrangement leads to abnormal production of ERG and promotes tumor progression. However, the mechanism by which ERG contributes to the tumorigenesis and drives the progression from primary to metastatic and hormone-refractor...
More

Three-year postdoctoral fellowship in the Molecular Oncology Group directed by Prof. Andrea Alimonti at the IOR

A 3-year postdoctoral fellowship is available from September 1st, 2021 in the lab of Prof. Andrea Alimonti at IOR to study the role of senescence and the immune response in prostate cancer and aging and to develop novel effective therapies for the treatment of prostate cancer and other aging-related disorders. The Alimonti lab works on senescence and cancer immunology, in particular on the role played by senescent cells and tumor-infiltrating myeloid cells in cancer initiation, progression and t...
More

Prestigious professorship awarded at the Institute of Oncology Research in Bellinzona

Stiftung Experimentelle Biomedizin has awarded Dr Arianna Calcinotto, Group Leader at the Institute of Oncology Research (IOR, affiliated to USI Università della Svizzera italiana) the Peter Hans Hofschneider Professorship 2020/2021. This is the third time the Zurich-based foundation has conferred the award in Switzerland. Arianna Calcinotto, who since 2019 heads the Cancer Immunotherapy research group at the IOR, has distinguished herself nationally and internationally for her work and relat...
More

IOR study reveals how breast cancer therapy may be effective against COVID-19

The so-called “Selective Estrogen Receptor Modulators (SERMs)” treatments used in breast cancer therapy may be effective against COVID-19. A study conducted by the Institute of Oncology Research (IOR, affiliated to USI) based on data obtained from the Veneto Tumor Registry (Italy) has observed a lower risk of developing the coronavirus disease for women affected by hormonal-driven cancers subjected to this type of therapy. The study, performed in collaboration with the VIMM-University of P...
More